Identification of novel and orally active spiroindoline NPY Y5 receptor antagonists
Authors:
- 1 March 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (6) , 1564-1568
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Design, syntheses, and structure–activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4′-piperidin]-1′-yl}benzimidazole derivativesBioorganic & Medicinal Chemistry Letters, 2008
- Discovery of novel orally active ureido NPY Y5 receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2008
- Synthesis of new thiophene and benzo[b]thiophene hydrazide derivatives as human NPY Y5 antagonistsBioorganic & Medicinal Chemistry Letters, 2004
- L-152,804: Orally Active and Selective Neuropeptide Y Y5 Receptor AntagonistBiochemical and Biophysical Research Communications, 2000
- The Novel Neuropeptide Y Y1 Receptor Antagonist J-104870: A Potent Feeding Suppressant with Oral BioavailabilityBiochemical and Biophysical Research Communications, 1999
- Cloning and characterization of a novel receptor to pancreatic polypeptide, a member of the neuropeptide Y receptor familyFEBS Letters, 1996
- Cloning and Functional Expression of a cDNA Encoding a Human Type 2 Neuropeptide Y ReceptorJournal of Biological Chemistry, 1995
- The murine NPY‐1 receptor gene Structure and delineation of tissue‐specific expressionFEBS Letters, 1992
- Neuroreptide Y: Stimulation of feeding and drinking by injection into the paraventricular nucleusLife Sciences, 1984
- Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptidesNature, 1980